Search results
Pfizer, Flagship name first target for multibillion-dollar collaboration: obesity
FierceBiotech· 4 days agoPfizer and Flagship Pioneering have settled on the first target for their billion-dollar,...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 5 days agoModerna became a household name thanks to the success of its mRNA vaccine against COVID-19. Along...
Are Dividend Stocks The Best Source Of Passive Income? Here Are Three Alternative Options To...
Benzinga via Yahoo Finance· 1 day agoPassive income is the dream for many investors, providing a steady stream of cash without the need...
Billionaires Are Buying These 2 Ultra-High-Yield Dividend Stocks Hand Over Fist. Are They Smart Buys...
The Motley Fool via AOL· 5 days agoThey buy dividend-paying stocks because they know that companies committed to returning a portion of earnings to shareholders tend to outperform ones that don't. In the first three months of ...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 3 days agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails -...
Benzinga· 1 day agoPfizer's PFE phase III study of investigational gene therapy, fordadistrogene movaparvovec, for...
Sarepta Jumps After Rival Gene Therapy From Pfizer Flops
Investor's Business Daily· 2 days agoThe news gives Sarepta Therapeutics (SRPT) an edge heading to June 21, when the Food and Drug Administration will decide whether to fully approve Elevidys for patients with the muscle-wasting ...
UPDATE: Pfizer's phase 3 gene therapy trial fails to improve function for boys with Duchenne...
FierceBiotech· 3 days agoPfizer’s phase 3 gene therapy trial has failed to demonstrate significant improvement in motor...
Bridgeway Capital Management LLC Boosts Stock Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 3 days agoBridgeway Capital Management LLC boosted its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 26.0% during the 4th quarter, according to its most recent 13F filing ...
Pfizer’s Phase III DMD gene therapy trial misses primary endpoint
Clinical Trials Arena via Yahoo Finance· 3 days agoPfizer has reported that its Phase III CIFFREO clinical trial of investigational mini-dystrophin...